INTRODUCTION {#sec1-1}
============

Pituitary apoplexy is a rare clinical syndrome caused by the rapid enlargement of a pituitary adenoma because of hemorrhage or infarction.\[[@ref5][@ref6][@ref9]--[@ref11]\] It usually presents with sudden onset of severe headache, vomiting, visual disturbance, ocular palsy, and consciousness disturbance. The patients with pituitary apoplexy, who exhibit no neuro-ophthalmological signs, can be conservatively treated.\[[@ref6][@ref9]--[@ref11]\] Although rare, deterioration at the chronic stage is caused by rebleeding within the hematoma or hemorrhagic change within the infarct area.

Enlargement of intracerebral hematoma without rebleeding in chronic phase is a rare but well-known clinical condition, and is well-described as chronic expanding intracerebral hematoma.\[[@ref1][@ref4][@ref7][@ref8][@ref14]\] The possible mechanism of hematoma enlargement is expansion due to serum exudation or repeated minor bleeding from capillaries of the hematoma capsule.\[[@ref14]\] However, expansion of an intrasellar pituitary hematoma without rebleeding at the chronic stage of pituitary apoplexy is an extremely rare clinical condition. Here, we report the first case of chronic expanding intrasellar hematoma without rebleeding after pituitary apoplexy.

CASE REPORT {#sec1-2}
===========

A 29-year-old male presented with a sudden onset of severe headache accompanied by vomiting, and visited a local hospital. A physician could not detect any abnormal finding by computed tomography (CT) scans. Two weeks after the onset, magnetic resonance imaging (MRI) revealed a pituitary mass with hematoma consistent with pituitary apoplexy \[Figure [1a](#F1){ref-type="fig"} and [b](#F1){ref-type="fig"}\], and he was referred to our institute. Neuro-ophthalmological examination revealed no visual field disturbance. Endocrinological evaluation showed that the prolactin level was elevated at 583.2 ng/mL (normal value: 3.6-16.3 ng/mL). Pituitary apoplexy due to a prolactinoma was the most likely diagnosis. He also complained of general fatigue and appetite loss. The adenocorticotropic hormone (ACTH) level was slightly decreased: 8 pg/mL (normal value: 7-56 pg/mL). The testosterone level was also decreased: 24.1 ng/dL (normal value: 161-904 ng/dL). Thus, hypopituitarism was proved and replacement therapy was started. Because he exhibited no neuro-ophthalmological deficit, we continued medical treatment.

![MR images obtained 2 weeks (a, b) and 3 weeks (c) after onset, (a) coronal T1-weighted image demonstrated intra-and suprasellar mass with a central area of high signal intensity consistent with hematoma of subacute phase. The hyperintense signal may correspond to hemoglobin degradation content as extracellular methhemoglobin, (b) sagittal postgadolinium T1-weighted image showed rim enhancement of hematoma capsule, (c) coronal T1-weighted image demonstrated enlargement of pituitary hematoma resulting in compression of the chiasm (arrows). No sign of rebleeding was detected. Compared with MR images obtained 2 weeks after onset (a), the compression of chiasm was markedly worsened for this one week (c, arrows)](SNI-4-41-g001){#F1}

Three weeks after the onset, he gradually began to complain of blurred vision. Neuro-ophthalmological examination revealed bitemporal upper quadrant hemianopsia. MRI showed the enlargement of the pituitary mass lesion resulting in the compression of the chiasm \[[Figure 1c](#F1){ref-type="fig"}\]. The intensity of the hematoma within the adenoma was changed from hyperintensity to hypointensity on T1-weighted image \[[Figure 1c](#F1){ref-type="fig"}\]. No sign of rebleeding was detected. Laboratory investigations revealed no abnormal values in hematological and coagulant parameters: Thrombocyte count, prothrombin time, and activated and partial thromboplastin times.

He was operated on via transsphenoidal approach. The dura of the sella was tensive. After dural opening, xanthochromic fluid spouted out, but no fresh clot could be detected within the hematoma cavity \[[Figure 2](#F2){ref-type="fig"}\]. The wall of the hematoma cavity was fibrous and thick, and had characteristics similar to the outer membrane of chronic subdural hematoma (CSDH). Grayish adenoma was detected and removed with curettage. Histological examination confirmed the diagnosis of pituitary adenoma. Postoperative course was uneventful. Visual field disturbance was completely resolved and hypopituitarism was gradually improved. Postoperative MRI showed that the cyst was evacuated and the chiasm was decompressed.

![Intraoperative microphotograph showing the content of hematoma. Xanthochromic fluid was spouted after dural opening (arrows)](SNI-4-41-g002){#F2}

DISCUSSION {#sec1-3}
==========

The clinical features of pituitary apoplexy are typically sudden in onset, including acute headache, nausea, vomiting, visual field defect, and ocular paresis.\[[@ref5][@ref6][@ref9]--[@ref11]\] After acute stage, these symptoms are gradually improved and deterioration is rare. Deterioration at chronic stage is usually caused by rebleeding within the hematoma or infarction. In the present case, visual field disturbance was developed at chronic state due to enlargement of the hematoma without rebleeding. This is the first case of chronic expanding intrasellar pituitary hematoma without rebleeding after pituitary adenoma. Previously, Veldhuis, *et al*. reported a case of chronic intrasellar hematoma.\[[@ref12]\] In this report, a chronic intrasellar hematoma mimicked recurrent tumor one year after operation for a prolactinoma. However, only plain X-ray film was presented in this report, because this case was treated in the pre-CT era. The feature of hematoma could not be examined in detail by imaging such as MRI. Hence, the present case is the first report of chronic expanding intrasellar hematoma, which is examined by MRI, without rebleeding after pituitary apoplexy.

The phenomenon of chronic expansion of hematoma is well-known in CSDH. In CSDH, various theories have been proposed to explain the enlargement of hematomas. Intermittent cycles of bleeding, coagulation, fibrinolysis, and rebleeding from the vascularized outer membrane are widely accepted to be the pathophysiology of hematoma expansion.\[[@ref3]\] Enlargement of CSDH without rebleeding is also well-known: Increased vascular permeability and subsequent serum exudation from the outer membrane may be involved in hematoma expansion without rebleeding.\[[@ref2][@ref3][@ref13]\] This mechanism can also explain the pathophysiology of pituitary hematoma expansion in the present case. The hematoma capsule of the present case was well-enhanced. Enhancement of the hematoma capsule may be the result of blood--brain barrier breakdown, resulting in plasma exudation. Intraoperative findings revealed the hematoma capsule of the present case was thickened and like outer membrane of CSDH, suggesting that the same mechanism with CSDH may be involved in the hematoma expansion of the present case. It is likely that serum exudation from the hematoma capsule is the cause of hematoma expansion without rebleeding in the present case.

CONCLUSION {#sec1-4}
==========

It was highly likely that the intrasellar pituitary hematoma expanded without rebleeding through the same mechanism as CSDH: Expansion due to serum exudation from capillaries of the hematoma capsule. To the authors' knowledge, this is the first documented case of chronic expanding intrasellar hematoma without rebleeding after pituitary apoplexy. Although it is unusual clinical condition, expansion of intrasellar pituitary hematoma without rebleeding at chronic stage should be taken into account in the treatment of pituitary apoplexy.
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